Erasca, Inc. Competitors
Symbol | Share Price | Market Cap | P/E Ratio | Employee Count | Revenue |
---|---|---|---|---|---|
![]() ARVN
Arvinas, Inc. |
$19.91 | $1.83 B | -4.41 | 430 | $263.40 M |
![]() BDTX
Black Diamond Therapeutics, Inc. |
$2.13 | $291.95 M | -3.13 | 24 | $0 |
![]() CCCC
C4 Therapeutics, Inc. |
$4.09 | $320.64 M | -1.97 | 110 | $20.76 M |
![]() CGEM
Cullinan Oncology, Inc. |
$11.78 | $1.29 B | -7.16 | 111 | $0 |
![]() DSGN
Design Therapeutics, Inc. |
$6.31 | $217.51 M | -3.7 | 54 | $0 |
![]() EWTX
Edgewise Therapeutics, Inc. |
$26.56 | $1.65 B | -11.47 | 110 | $0 |
![]() GLUE
Monte Rosa Therapeutics, Inc. |
$6.89 | $243.38 M | -1.59 | 133 | $0 |
![]() GRCL
Gracell Biotechnologies Inc. |
$10.25 | $989.87 M | -10.57 | 314 | $0 |
![]() IPSC
Century Therapeutics, Inc. |
$1.05 | $244.54 M | -1.32 | 152 | $2.24 M |
![]() KROS
Keros Therapeutics, Inc. |
$15.64 | $1.76 B | -9.45 | 169 | $3.55 M |
![]() LIFE
aTyr Pharma, Inc. |
$1.90 | $131.12 M | -2.16 | 56 | $353,000 |
![]() MLYS
Mineralys Therapeutics, Inc. |
$13.05 | $652.38 M | -6.03 | 51 | $0 |
![]() NGM
NGM Biopharmaceuticals, Inc. |
$1.54 | $128.53 M | -0.89 | 138 | $4.42 M |
![]() OLMA
Olema Pharmaceuticals, Inc. |
$5.50 | $734.41 M | -6.56 | 87 | $0 |
![]() PLRX
Pliant Therapeutics, Inc. |
$13.18 | $672.63 M | -3.9 | 171 | $0 |
![]() RLAY
Relay Therapeutics, Inc. |
$4.57 | $1.05 B | -3 | 261 | $10.01 M |
![]() SANA
Sana Biotechnology, Inc. |
$1.75 | $1.55 B | -4.59 | 328 | $0 |
![]() STOK
Stoke Therapeutics, Inc. |
$11.02 | $774.50 M | -6.14 | 110 | $8.78 M |
![]() THRX
Theseus Pharmaceuticals, Inc. |
$4.07 | $181.50 M | -3.03 | 38 | $0 |
![]() ZNTL
Zentalis Pharmaceuticals, Inc. |
$3.13 | $754.16 M | -3.26 | 124 | $0 |